These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2204739)

  • 1. Low-dose aspirin for migraine prophylaxis.
    Buring JE; Peto R; Hennekens CH
    JAMA; 1990 Oct; 264(13):1711-3. PubMed ID: 2204739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose aspirin for migraine prophylaxis in women.
    Benseñor IM; Cook NR; Lee IM; Chown MJ; Hennekens CH; Buring JE
    Cephalalgia; 2001 Apr; 21(3):175-83. PubMed ID: 11442551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Clopidogrel and Aspirin vs Aspirin Alone on Migraine Headaches After Transcatheter Atrial Septal Defect Closure: The CANOA Randomized Clinical Trial.
    Rodés-Cabau J; Horlick E; Ibrahim R; Cheema AN; Labinaz M; Nadeem N; Osten M; Côté M; Marsal JR; Rivest D; Marrero A; Houde C
    JAMA; 2015 Nov; 314(20):2147-54. PubMed ID: 26551304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin prophylaxis in migraine.
    O'Neill BP; Mann JD
    Lancet; 1978 Dec; 2(8101):1179-81. PubMed ID: 82144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial.
    Diener HC; Agosti R; Allais G; Bergmans P; Bussone G; Davies B; Ertas M; Lanteri-Minet M; Reuter U; Sánchez Del Río M; Schoenen J; Schwalen S; van Oene J;
    Lancet Neurol; 2007 Dec; 6(12):1054-62. PubMed ID: 17988947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous dexamethasone vs placebo as adjunctive therapy to reduce the recurrence rate of acute migraine headaches: a multicenter, double-blinded, placebo-controlled randomized clinical trial.
    Donaldson D; Sundermann R; Jackson R; Bastani A
    Am J Emerg Med; 2008 Feb; 26(2):124-30. PubMed ID: 18272089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroids for migraine headaches: a randomized double-blind, two-armed, placebo-controlled trial.
    Fiesseler FW; Shih R; Szucs P; Silverman ME; Eskin B; Clement M; Saxena R; Allegra J; Riggs RL; Majlesi N
    J Emerg Med; 2011 Apr; 40(4):463-8. PubMed ID: 19846269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.
    Cady RK; Mathew N; Diener HC; Hu P; Haas M; Novak GP;
    Headache; 2009 Feb; 49(2):216-26. PubMed ID: 19222595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Migraine and subsequent risk of stroke in the Physicians' Health Study.
    Buring JE; Hebert P; Romero J; Kittross A; Cook N; Manson J; Peto R; Hennekens C
    Arch Neurol; 1995 Feb; 52(2):129-34. PubMed ID: 7848119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
    Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related maculopathy in a randomized trial of low-dose aspirin among US physicians.
    Christen WG; Glynn RJ; Ajani UA; Schaumberg DA; Chew EY; Buring JE; Manson JE; Hennekens CH
    Arch Ophthalmol; 2001 Aug; 119(8):1143-9. PubMed ID: 11483080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetaminophen, aspirin, and caffeine in combination versus ibuprofen for acute migraine: results from a multicenter, double-blind, randomized, parallel-group, single-dose, placebo-controlled study.
    Goldstein J; Silberstein SD; Saper JR; Ryan RE; Lipton RB
    Headache; 2006 Mar; 46(3):444-53. PubMed ID: 16618262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women.
    Ridker PM; Hennekens CH; Tofler GH; Lipinska I; Buring JE
    J Cardiovasc Risk; 1996 Apr; 3(2):209-12. PubMed ID: 8836865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
    MacGregor EA; Brandes JL; Silberstein S; Jeka S; Czapinski P; Shaw B; Pawsey S
    Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin is efficacious for the treatment of acute migraine.
    Lipton RB; Goldstein J; Baggish JS; Yataco AR; Sorrentino JV; Quiring JN
    Headache; 2005 Apr; 45(4):283-92. PubMed ID: 15836564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet antagonists in migraine prophylaxis. A clinical trial using aspirin and dipyridamole.
    Masel BE; Chesson AL; Peters BH; Levin HS; Alperin JB
    Headache; 1980 Jan; 20(1):13-8. PubMed ID: 6985888
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study.
    Bigal ME; Edvinsson L; Rapoport AM; Lipton RB; Spierings EL; Diener HC; Burstein R; Loupe PS; Ma Y; Yang R; Silberstein SD
    Lancet Neurol; 2015 Nov; 14(11):1091-100. PubMed ID: 26432181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.